Current Edition

News

FDA approval for Novartis' melanoma combo

The FDA has approved Novartis' Tafinlar(dabrafenib) in combination with Mekinist (trametinib) for the adjuvant treatment of BRAF V600E or V600K mutation-positiv...
Continue Reading →